[1] |
HOOFNAGLE JH, BONKOVSKY HL, PHILLIPS EJ, et al. HLA-B*35: 01 and green tea-Induced liver injury[J]. Hepatology, 2021, 73(6): 2484-2493. DOI: 10.1002/hep.31538.
|
[2] |
CHALASANI NP, MADDUR H, RUSSO MW, et al. ACG clinical guideline: diagnosis and management of idiosyncratic drug-induced liver injury[J]. Am J Gastroenterol, 2021, 116(5): 878-898. DOI: 10.14309/ajg.0000000000001259.
|
[3] |
FONTANA RJ, LIOU I, REUBEN A, et al. AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury[J]. Hepatology, 2022. DOI: 10.1002/hep.32689.[Online ahead of print]
|
[4] |
ZHAO T, LI C, WANG S, et al. Green Tea (Camellia sinensis): A review of its phytochemistry, pharmacology, and toxicology[J]. Molecules, 2022, 27(12): 3909. DOI: 10.3390/molecules27123909.
|
[5] |
YE Q, LIU Y, CHEN JP, et al. Research progress on chemical constituents and pharmacological activities of green tea[J]. Drug Evaluation Research, 2021, 44(12): 2171-2719. DOI: 10.7501/j.issn.1674-6376.2021.12.026.
叶晴, 刘毅, 陈金鹏, 等. 绿茶化学成分及药理作用研究进展[J]. 药物评价研究, 2021, 44(12): 2711-2719. DOI: 10.7501/j.issn.1674-6376.2021.12.026.
|
[6] |
RUAN YC, WANG YG. Biochemical basis for the mellow, fresh and thick taste quality of green tea[J]. Tea Communication, 1987, 4: 3-6, 17. https://www.cnki.com.cn/Article/CJFDTOTAL-CYTX198704000.htm
阮宇成, 王月根. 绿茶滋味品质醇、鲜、浓的生化基础[J]. 茶叶通讯, 1987, 4: 3-6, 17. https://www.cnki.com.cn/Article/CJFDTOTAL-CYTX198704000.htm
|
[7] |
JIMENEZ-SAENZ M, MARTINEZ-SANCHEZ MDEL C. Acute hepatitis associated with the use of green tea infusions[J]. J Hepatol, 2006, 44(3): 616-617. DOI: 10.1016/j.jhep.2005.11.041.
|
[8] |
FEDERICO A, TISO A, LOGUERCIO C. A case of hepatotoxicity caused by green tea[J]. Free Radic Biol Med, 2007, 43(3): 474. DOI: 10.1016/j.freeradbiomed.2007.05.010.
|
[9] |
OKETCH-RABAH HA, ROE AL, RIDER CV, et al. United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts[J]. Toxicol Rep, 2020, 7: 386-402. DOI: 10.1016/j.toxrep.2020.02.008.
|
[10] |
PASRIJA D, ANANDHARAMAKRISHNAN C. Techniques for extraction of green tea polyphenols: a review[J]. Food Bioproc Tech, 2015, 8(5): 935-950. DOI: 10.1007/s11947-015-1479-y.
|
[11] |
ZHENG EX, ROSSI S, FONTANA RJ, et al. Risk of liver injury associated with green tea extract in SLIMQUICK(R) weight loss products: results from the DILIN prospective study[J]. Drug Saf, 2016, 39(8): 749-754. DOI: 10.1007/s40264-016-0428-7.
|
[12] |
GARCÍA-CORTÉS M, ROBLES-DÍAZ M, ORTEGA-ALONSO A, et al. Hepatotoxicity by dietary supplements: a tabular listing and clinical characteristics[J]. Int J Mol Sci, 2016, 17(4): 537. DOI: 10.3390/ijms17040537.
|
[13] |
CHO T, WANG X, YEUNG K, et al. Liver Injury caused by green tea extract in PD-1-/- mice: an impaired immune tolerance model for idiosyncratic drug-induced liver injury[J]. Chem Res Toxicol, 2021, 34(3): 849-856. DOI: 10.1021/acs.chemrestox.0c00485.
|
[14] |
MAH E, CHEN O, LISKA DJ, et al. Dietary supplements for weight management: a narrative review of safety and metabolic health benefits[J]. Nutrients, 2022, 14(9): 1787. DOI: 10.3390/nu14091787.
|
[15] |
ZHU Y, LIU SH, WANG JB, et al. Clinical analysis of drug-induced liver injury caused by polygonum multiflorum and its preparations[J]. Chin J Integr Tradit West Med, 2015, 35(12): 1442-1447. DOI: 10.7661 /CJIM.2015.12.1442.
朱云, 刘树红, 王伽伯, 等. 何首乌及其制剂导致药物性肝损伤的临床分析[J]. 中国中西医结合杂志, 2015, 35(12): 1442-1447. DOI: 10.7661/CJIM.2015.12.1442.
|
[16] |
LI C, RAO T, CHEN X, et al. HLA-B*35: 01 allele is a potential biomarker for predicting polygonum multiflorum-induced liver injury in humans[J]. Hepatology, 2019, 70(1): 346-357. DOI: 10.1002/hep.30660.
|
[17] |
AITHAL GP. Of potions, poisons, polygonum, and pre-emptive polymorphism[J]. Hepatology, 2019, 70(1): 8-10. DOI: 10.1002/hep.30798.
|
[18] |
YANG WN, PANG LL, ZHOU JY, et al. Single-nucleotide polymorphisms of HLA and Polygonum multiflorum-induced liver injury in the Han Chinese population[J]. World J Gastroenterol, 2020, 26(12): 1329-1339. DOI: 10.3748/wjg.v26.i12.1329.
|
[19] |
SHI Z, ZHU JX, GUO YM, et al. Epigallocatechin gallate during dietary restriction - potential mechanisms of enhanced liver injury[J]. Front Pharmacol, 2020, 11: 609378. DOI: 10.3389/fphar.2020.609378.
|
[20] |
ZAREZADEH M, SAEDISOMEOLIA A, SHEKARABI M, et al. The effect of obesity, macronutrients, fasting and nutritional status on drug-metabolizing cytochrome P450s: a systematic review of current evidence on human studies[J]. Eur J Nutr, 2021, 60(6): 2905-2921. DOI: 10.1007/s00394-020-02421-y.
|
[21] |
KAPETANOVIC IM, CROWELL JA, KRISHNARAJ R, et al. Exposure and toxicity of green tea polyphenols in fasted and non-fasted dogs[J]. Toxicology, 2009, 260(1-3): 28-36. DOI: 10.1016/j.tox.2009.03.007.
|
[22] |
CHOW HH, HAKIM IA, VINING DR, et al. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals[J]. Clin Cancer Res, 2005, 11(12): 4627-4633. DOI: 10.1158/1078-0432.CCR-04-2549.
|
[23] |
HOOFNAGLE JH, BJÖRNSSON ES. Drug-induced liver injury-types and phenotypes[J]. N Engl J Med, 2019, 381(3): 264-273. DOI: 10.1056/NEJMra1816149.
|
[24] |
LOUVET A, MATHURIN P. Alcoholic liver disease: mechanisms of injury and targeted treatment[J]. Nat Rev Gastroenterol Hepatol, 2015, 12(4): 231-242. DOI: 10.1038/nrgastro.2015.35.
|
[25] |
ROCCO A, COMPARE D, ANGRISANI D, et al. Alcoholic disease: liver and beyond[J]. World J Gastroenterol, 2014, 20(40): 14652-14659. DOI: 10.3748/wjg.v20.i40.14652.
|
[26] |
CEDERBAUM AI. Alcohol metabolism[J]. Clin Liver Dis, 2012, 16(4): 667-685. DOI: 10.1016/j.cld.2012.08.002.
|
[27] |
HU J, WEBSTER D, CAO J, et al. The safety of green tea and green tea extract consumption in adults-Results of a systematic review[J]. Regul Toxicol Pharmacol, 2018, 95: 412-433. DOI: 10.1016/j.yrtph.2018.03.019.
|